UBS ETC on CMCI Corn USD logo

UBS ETC on CMCI Corn USD (CORU)

Market Closed
20 May, 15:30
$
74. 69
+1.5
+2.05%
$
- Market Cap
2.2% Div Yield
0 Volume
$ 73.19
Previous Close
Day Range
74.69 74.69
Year Range
67 78
Earnings results expected in 49 days

Summary

CORU closed Tuesday higher at $74.69, an increase of 2.05% from Monday's close, completing a monthly decrease of -1.67% or $1.27. Over the past 12 months, CORU stock gained 0.55%.
CORU pays dividends to its shareholders, with the most recent payment made on Jun 02, 2025. The next estimated payment will be in In 2 months on Sep 02, 2025 for a total of $0.55.
The last earnings report, released on Apr 29, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.12%, based on the last three reports. The next scheduled earnings report is due on Jul 29, 2025.
The stock of the company had never split.
The company's stock is traded on 7 different exchanges and in various currencies, with the primary listing on NYSE (USD).
Want to track CORU and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

CORU Chart

Chart

Empty chart
The chart has 2 Y axes displaying values, and values.
Loading, please wait...
End of interactive chart.
Nittetsu Mining Provides $1.5 Million Fifth Earn-in Payment for Camino's Los Chapitos Project

Nittetsu Mining Provides $1.5 Million Fifth Earn-in Payment for Camino's Los Chapitos Project

VANCOUVER, BC / ACCESS Newswire / June 5, 2025 / Camino Minerals Corporation (TSXV:COR)(OTC PINK:CAMZF) ("Camino" or the "Company") is pleased to announce the receipt of CAD$1.5 million from exploration partner Nittetsu Mining CO., Ltd. ("Nittetsu") to fully fund the upcoming exploration and drilling campaign at Camino's Los Chapitos Copper Project ("Los Chapitos" or the "Project") in Peru.

Accessnewswire | 4 days ago
Here's Why You Should Add Cencora Stock to Your Portfolio Now

Here's Why You Should Add Cencora Stock to Your Portfolio Now

COR continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.

Zacks | 1 week ago
Cencora Continues To Deliver As A Healthcare Distributor With Further Growth Signs

Cencora Continues To Deliver As A Healthcare Distributor With Further Growth Signs

Cencora gets a buy rating, agreeing with today's consensus from Wall St. The sector and macro environment points to continued demand for the healthcare supplies and niche specialty drugs Cencora can distribute. Future share price targets point to significant potential upside over 3 years, justifying a buy despite the stock trading above average now.

Seekingalpha | 3 weeks ago

UBS ETC on CMCI Corn USD Dividends

Cencora Inc. logo
COR In 2 months
Estimated
Quarterly
$0.55 Per Share
Cencora Inc. logo
COR 3 weeks ago
Paid
Quarterly
$0.55 Per Share
Cencora Inc. logo
COR 3 months ago
Paid
Quarterly
$0.55 Per Share
Cencora Inc. logo
COR 6 months ago
Paid
Quarterly
$0.55 Per Share
Cencora Inc. logo
COR 10 months ago
Paid
Quarterly
$0.51 Per Share
Cencora Inc. logo
COR 9 May 2024
Paid
Quarterly
$0.51 Per Share

UBS ETC on CMCI Corn USD Earnings

29 Jul 2025 (49 Days) Date
-
Cons. EPS
-
EPS
29 Apr 2025 Date
-
Cons. EPS
-
EPS
29 Jan 2025 Date
3.49
Cons. EPS
3.73
EPS
6 Nov 2024 Date
3.22
Cons. EPS
3.34
EPS
31 Oct 2024 Date
3.2
Cons. EPS
3.34
EPS
Cencora Inc. logo
COR In 2 months
Estimated
Quarterly
$0.55 Per Share
Cencora Inc. logo
COR 3 weeks ago
Paid
Quarterly
$0.55 Per Share
Cencora Inc. logo
COR 3 months ago
Paid
Quarterly
$0.55 Per Share
Cencora Inc. logo
COR 6 months ago
Paid
Quarterly
$0.55 Per Share
Cencora Inc. logo
COR 10 months ago
Paid
Quarterly
$0.51 Per Share
Cencora Inc. logo
COR 9 May 2024
Paid
Quarterly
$0.51 Per Share
29 Jul 2025 (49 Days) Date
-
Cons. EPS
-
EPS
29 Apr 2025 Date
-
Cons. EPS
-
EPS
29 Jan 2025 Date
3.49
Cons. EPS
3.73
EPS
6 Nov 2024 Date
3.22
Cons. EPS
3.34
EPS
31 Oct 2024 Date
3.2
Cons. EPS
3.34
EPS

UBS ETC on CMCI Corn USD (CORU) FAQ

What is the stock price today?

The current price is $74.69.

On which exchange is it traded?

UBS ETC on CMCI Corn USD is listed on NYSE.

What is its stock symbol?

The ticker symbol is CORU.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

What is the earnings per share?

The EPS is 0.

When is the next earnings date?

The next earnings report will release on Jul 29, 2025.

Has UBS ETC on CMCI Corn USD ever had a stock split?

UBS ETC on CMCI Corn USD had 0 splits and the recent split was on Jun 16, 2009.

UBS ETC on CMCI Corn USD Profile

LSE Exchange
US Country

Overview

Cencora, Inc., previously known as AmerisourceBergen Corporation, represents a cornerstone in the pharmaceutical distribution industry. Established in 2001 and headquartered in Conshohocken, Pennsylvania, the company specializes in sourcing and distributing pharmaceutical products across various markets. Its operation spans a comprehensive array of services targeted at facilitating the accessibility and distribution of pharmaceuticals, healthcare products, and related services. Cencora's business operations are segmented into U.S. Healthcare Solutions and International Healthcare Solutions, each catering to a diverse range of customers and needs within the healthcare and pharmaceutical sectors.

Products and Services

U.S. Healthcare Solutions:

  • Distribution Services: Includes distributing pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a wide range of healthcare providers such as acute care hospitals, retail pharmacies, and mail order pharmacies.
  • Pharmacy Management and Consulting Services: Offers pharmacy management, staffing, supply management software, and consulting services to retail and institutional healthcare providers.
  • Packaging Solutions: Provides innovative packaging solutions to institutional and retail healthcare providers to ensure safety and efficiency in medication dispensing.
  • Support Services for Clinical Trials: Offers clinical trial support, product post-approval, and commercialization support services, coupled with data analytics and research services for biotechnology and pharmaceutical manufacturers.
  • Veterinary Products and Services: Distributes pharmaceuticals, vaccines, and other products for companion and production animals, along with providing sales force services to manufacturers.
  • Specialty Products and Services: Involves the distribution of plasma and other blood products, injectable pharmaceuticals, vaccines, and offers services to physicians specializing in various disease states, including oncology, hospitals, and dialysis clinics.

International Healthcare Solutions:

  • Pharmaceutical Wholesale and Related Service: Offers international pharmaceutical wholesale, distribution, and related services to pharmacies, doctors, health centers, and hospitals primarily in Europe.
  • Global Commercialization Services: Provides global commercialization services to enhance the reach and impact of pharmaceutical products across international markets.
  • Specialty Transportation and Logistics: Delivers specialty transportation and logistics services tailored for the biopharmaceutical industry, focusing on the secure and efficient delivery of pharmaceutical products.

Contact Information

Address: 1 West First Avenue
Phone: 610 727 7000